Ładuje się......
Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
Non-alcoholic steatohepatitis (NASH) is becoming a leading cause of cirrhosis with the burden of NASH-related complications projected to increase massively over the coming years. Several molecules with different mechanisms of action are currently in development to treat NASH, although reported effic...
Zapisane w:
| Wydane w: | Gut |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMJ Publishing Group
2020
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497577/ https://ncbi.nlm.nih.gov/pubmed/32381514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2019-319104 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|